Literature DB >> 31144103

Neuroprotective effects of lovastatin in the pilocarpine rat model of epilepsy according to the expression of neurotrophic factors.

Pooyan Moradi1, Mahin Ganjkhani2, Iraj Jafari Anarkooli3, Alireza Abdanipour4.   

Abstract

Studies have suggested that neurotrophic factors (NTFs) are involved in the status epilepticus development. This indicates their essential role in mediating acquired epileptic conditions. Therefore, modulating the expression of NTFs may inhibit seizure-induced cell loss in the epileptic lesions. In this study, we examined the anti-apoptotic, anti-necrotic and regulatory effects of lovastatin on the expression of NTFs in the pilocarpine rat model of temporal lobe epilepsy (TLE). A total of 32 male Wistar rats were divided into 4 groups (n = 8 per group): i) normal; ii) non-treated epileptic group [intraperitoneal (i.p.) administration of 350-400 mg/kg pilocarpine]; iii) treatment group (pilocarpine-treated rats treated followed by 5 mg/kg lovastatin); and iv) vehicle epileptic rats treated with Carboxymethyl cellulose (CMC). Animals that had a behavioral score of 4-5 according to the Racine scale were selected for study participation. Three days after the first seizure, pilocarpine-treated rats received i.p. injections of lovastatin for 14 days. The rats were killed and prepared for histopathologic analysis as well as real-time RT-PCR 17 days after the first seizure. The results of this study showed increased mRNA expression of glial cell line-derived neurotrophic factor (GDNF) and Ciliary neurotrophic factor (CNTF) and decreased expressions of Brain-derived neurotrophic factor (BDNF), Neurotrophin-3 (NT-3), and Neurotrophin-4 (NT-4) mRNA in the epileptic rats treated with lovastatin. Histological analysis of neurodegeneration in the brain sections showed that the number of hippocampal apoptotic and necrotic cells significantly decreased in the treatment groups. Furthermore, numerical density of neurons per area was significantly higher in the treated groups compared with the untreated groups. Collectively, the results of this study have shown that lovastatin could attenuate seizure-induced expression of neurotrophic factors and consequently reduce hippocampal cell death in the pilocarpine rat model of TLE.

Entities:  

Keywords:  Lovastatin; Neurotrophic factors; Pilocarpine; Temporal lobe epilepsy

Mesh:

Substances:

Year:  2019        PMID: 31144103     DOI: 10.1007/s11011-019-00424-1

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  38 in total

1.  The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis.

Authors:  Linda Kalilani; Xuezheng Sun; Barbara Pelgrims; Matthias Noack-Rink; Vicente Villanueva
Journal:  Epilepsia       Date:  2018-11-13       Impact factor: 5.864

2.  Continuous infusion of neurotrophin-3 triggers sprouting, decreases the levels of TrkA and TrkC, and inhibits epileptogenesis and activity-dependent axonal growth in adult rats.

Authors:  B Xu; B Michalski; R J Racine; M Fahnestock
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

3.  HMG-CoA Reductase Inhibitors Bind to PPARα to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice.

Authors:  Avik Roy; Malabendu Jana; Madhuchhanda Kundu; Grant T Corbett; Suresh B Rangaswamy; Rama K Mishra; Chi-Hao Luan; Frank J Gonzalez; Kalipada Pahan
Journal:  Cell Metab       Date:  2015-06-25       Impact factor: 27.287

4.  Neuronal loss induced in limbic pathways by kindling: evidence for induction of hippocampal sclerosis by repeated brief seizures.

Authors:  J E Cavazos; I Das; T P Sutula
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

5.  Statins Enhance Expression of Growth Factors and Activate the PI3K/Akt-mediated Signaling Pathway after Experimental Intracerebral Hemorrhage.

Authors:  Dongmei Yang; Yuxia Han; Jianfeng Zhang; Michael Chopp; Donald M Seyfried
Journal:  World J Neurosci       Date:  2012-05-29

6.  Prolonged infusion of tetrodotoxin does not block mossy fiber sprouting in pilocarpine-treated rats.

Authors:  Paul S Buckmaster
Journal:  Epilepsia       Date:  2004-05       Impact factor: 5.864

7.  In the lithium-pilocarpine model of epilepsy, brain lesions are not linked to changes in blood-brain barrier permeability: an autoradiographic study in adult and developing rats.

Authors:  Claire Leroy; Catherine Roch; Estelle Koning; Izzie J Namer; Astrid Nehlig
Journal:  Exp Neurol       Date:  2003-08       Impact factor: 5.330

8.  Molecular analysis and characterization of zebrafish keratocan (zKera) gene.

Authors:  Lung-Kun Yeh; Chia-Yang Liu; Chung-Liang Chien; Richard L Converse; Winston W-Y Kao; Muh-Shy Chen; Fung-Rong Hu; Fon-Jou Hsieh; I-Jong Wang
Journal:  J Biol Chem       Date:  2007-10-26       Impact factor: 5.157

Review 9.  Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy.

Authors:  Tuane Bazanella Sampaio; Anne Suely Savall; Maria Eduarda Ziani Gutierrez; Simone Pinton
Journal:  Neural Regen Res       Date:  2017-04       Impact factor: 5.135

10.  A review of the epidemiology of temporal lobe epilepsy.

Authors:  Jose F Téllez-Zenteno; Lizbeth Hernández-Ronquillo
Journal:  Epilepsy Res Treat       Date:  2011-12-29
View more
  3 in total

1.  Increased ciliary neurotrophic factor in blood serum and lacrimal fluid as a potential biomarkers of focal epilepsy.

Authors:  Alexander Shpak; Alla Guekht; Tatiana Druzhkova; Flora Rider; Anna Gudkova; Natalia Gulyaeva
Journal:  Neurol Sci       Date:  2021-05-24       Impact factor: 3.307

2.  Comprehensive and scalable quantification of splicing differences with MntJULiP.

Authors:  Guangyu Yang; Sarven Sabunciyan; Liliana Florea
Journal:  Genome Biol       Date:  2022-09-14       Impact factor: 17.906

3.  Baicalin Rescues Cognitive Dysfunction, Mitigates Neurodegeneration, and Exerts Anti-Epileptic Effects Through Activating TLR4/MYD88/Caspase-3 Pathway in Rats.

Authors:  Jiali Yang; Zhixia Jia; Zhigang Xiao; Jing Zhao; Ye Lu; Li Chu; Hui Shao; Lin Pei; Shaodan Zhang; Yuan Chen
Journal:  Drug Des Devel Ther       Date:  2021-07-20       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.